Universal Time: 13:07  |  Local Time: 13:07 (0h GMT)
Select your timezone:

P-1.05 Nutritional management to avoid metabolic decompensation at major surgeries in a patient with propionic acidemia related cardiomyopathy: A case report

Hiromi Takenaka, Japan

Pharmacist
Department of pharmacy
National Cerebral and Cardiovascular Center

Abstract

Nutritional management to avoid metabolic decompensation at major surgeries in a patient with propionic acidemia related cardiomyopathy: A case report

Hiromi Takenaka1, Kenta Minagawa2, Kaori Yamanishi1, Ayumi Fukuda1, Akira Oita1, Kyoichi Wada3, Keiichiro Iwasaki5, Koichi Toda4, Kensuke Kuroda5, Osamu Seguchi5, Masanobu Yanase5, Norihide Fukushima2,5.

1Pharmacy, National Cerebral and Cardiovascular Center, Osaka, Japan; 2Clinical Nutrition, National Cerebral and Cardiovascular Center, Osaka, Japan; 3Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan; 4Pediatric Cardiology, Saitama Medical University International Medical Center, Saitama, Japan; 5Transplant Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan

Introduction: Propionic acidemia (PA) is a rare autosomal recessive metabolic disorder, which is rarely associated with cardiomyopathy. Since the serious metabolic decompensation, acidosis, ketonuria, and hyperammonemia, are triggered by catabolic stress such as infection, surgery, or inadequate nutrition, nutritional management is important and contributes to treatment.
We report a case with PA related cardiomyopathy who required special nutritional management to prevent metabolic decompensation at implantation and removal of left ventricular assist device (LVAD) and heart transplantation (HTx).
Case: A 19-year-old previously healthy man experienced the first episode of heart failure at 16 years of age. He underwent LVAD (Jarvik2000) implantation as bridge to transplantation at 18. He had recurrent LVAD driveline infections and subsequent sepsis triggering acidosis and hyperammonemia 1.5 years after implantation. He was diagnosed with late onset PA and special nutritional management for PA was started.
He underwent LVAD removal due to pump infection 2 months later and required inotropes until he underwent HTx at 19 years of age.
Nutritional management after LVAD removal and heart transplant, were carefully performed based on the previous experience. To prevent metabolic decompensation triggered by surgical catabolic stress, vitamin cocktail (Vitamin B1, B2, B12, C, and Ubidecarenone), biotin, L-carnitine, and parenteral nutrition consisting of glucose and amino acid were given immediately after surgery. Elevation of blood lactate and ammonia early post-op were resolved by higher glucose intake and lower protein intake and mechanical ventilation was discontinued 5 days after LVAD removal. Therefore, intravenous high dose glucose administration was started the day before HTx and no increase in blood ammonia was observed and he was exutubated 1 days after HTx. After starting oral intake, protein restricted diet and special milk formula for PA without isoleucine, valine, methionine, or threonine were gradually increased. Glucose infusion was continued until he had adequate dietary intake. Medium chain triglyceride (MCT)-oil administration waited for improved ketoacidosis to avoid ketone synthesis. Although lactate slightly increased for several days after surgery, the postoperative course was uneventful.
Discussion: In patients with PA related cardiomyopathy, meticulous nutritional management based on pathophysiology of PA is useful to prevent metabolic crisis at major surgery, such as LVAD implantation and HTx.

Comments

There are no comments yet...

WebApp Sponsor

© 2022 TTS 2020